Allogene Therapeutics, Inc. (ALLO) › Total AssetsAllogene Therapeutics, Inc. (ALLO) — Total AssetsAnnual figures by fiscal year, from SEC filings.2018: $773.86M2019: $717.80M2020: $1.23B2021: $1.05B2022: $821.58M2023: $642.84M2024: $548.71M2025: $415.90M$415.90M2018Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$415.90M-24.2%2024$548.71M-14.6%2023$642.84M-21.8%2022$821.58M-21.8%2021$1.05B-14.4%2020$1.23B+71.1%2019$717.80M-7.2%2018$773.86M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share